P. Combemale

108 papers receiving 3.5k citations

P. Combemale's Hit Papers

Adjuvant pembrolizumab versus placebo in resected stage III melanoma (EORTC 1325-MG/KEYNOTE-054): distant metastasis-free survival results from a double-blind, randomised, controlled, phase 3 trial 2021 · 300 citations
3000+1+3Years since publication100200300

Peers

P. Combemale
Comparison fields: 5 of 103
  • Neurology 452
  • Dermatology 260
  • Oncology 630
  • Epidemiology 762
  • Rehabilitation 137
Replace Nicolás Ortonne with:
Nicolás Ortonne France
Norbert T. Sepp Austria
Neil A. Swanson United States
C. Bédane France
Bernhard W. H. Zelger Austria
Celia Requena Spain
Omar Pastor Sangüeza United States
John C. Maize United States
Philippe Guilpain France
Keon Hee Yoo South Korea
P. Combemale relative to Nicolás Ortonne France Nicolás Ortonne's profile →
Citations per field
00.5×2×4×5.5×
Nicolás Ortonne · 1×
Citations per year

Countries citing papers authored by P. Combemale

Since Specialization
Citations

This map shows the geographic impact of P. Combemale's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by P. Combemale with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites P. Combemale more than expected).

Fields of papers citing papers by P. Combemale

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by P. Combemale. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by P. Combemale. The network helps show where P. Combemale may publish in the future.

Co-authors

The 25 scholars most cited alongside P. Combemale, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with P. Combemale Line = papers co-authored together P. Combemale links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 116 papers — load more, or switch the sort, to bring in the rest.

#Work
1 2015357
2
Adjuvant pembrolizumab versus placebo in resected stage III melanoma (EORTC 1325-MG/KEYNOTE-054): distant metastasis-free survival results from a double-blind, randomised, controlled, phase 3 trial
Hit paper breakdown →
2021300
3 2017159
4 2016157
5 2019147
6 2016139
7 1990129
8 2009127
9 2020120
10 1994111
11 2015105
12 198989
13 201485
14 200882
15 200980
16 201278
17 201769
18
The atrophic variant of dermatofibrosarcoma protuberans in childhood: a report of six cases.
199864
19 200759
20 202159

About P. Combemale

P. Combemale is a scholar working on Dermatology, Neurology, Epidemiology, Oncology and Rheumatology, having authored 116 papers that have together received 3.7k indexed citations. Recurring topics across this work include Neurofibromatosis and Schwannoma Cases (15 papers), Nonmelanoma Skin Cancer Studies (11 papers), Cutaneous Melanoma Detection and Management (8 papers), Hedgehog Signaling Pathway Studies (7 papers), Psoriasis: Treatment and Pathogenesis (5 papers), Cancer and Skin Lesions (5 papers), Nail Diseases and Treatments (5 papers) and Autoimmune Bullous Skin Diseases (4 papers). The work is most often cited by research in Neurology (452 citations), Dermatology (260 citations), Oncology (630 citations), Epidemiology (762 citations) and Rehabilitation (137 citations). P. Combemale has collaborated with scholars based in France, United States and Switzerland. Frequent co-authors include Jean Kanitakis, P. Wolkenstein, Salah Ferkal, S. Pinson, Catherine Prost‐Squarcioni, L. Valeyrie‐Allanore, Philippe Bernard, C. Bédane, Louis Dubertret and Thomas Mognetti. Their work appears in journals such as Journal of the European Academy of Dermatology and Venereology, British Journal of Dermatology, Annals of Oncology, Journal of Investigative Dermatology and Dermatology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact